As the problem of COVID-19 vaccines supplies so potently illustrates, it is time to rethink the EU’s pandemic preparedness strategy. More support is needed for late stage clinical development and large scale manufacturing

Commission’s Sandra Gallina says spending more on advance purchase agreements would not have avoided the current supply problems, after days of criticism of the bloc's centralised procurement scheme

‘AstraZeneca has to deliver’, the EU’s health chief says, as row over supplies heats up and officials contradict claims made by pharma company’s CEO

Leaked draft work programme points to an unhealthy balance between fundamental biology and applied research

Pharma company shoots down media report, as an extraordinary row over vaccines supply in Europe gets uglier

As they celebrate science being back in the mainstream of US policy, researchers are urging the new president to reboot the cancer programme that he championed as vice president

US is back in the World Health Organisation and the Paris climate agreement, but researchers predict the new president’s clean energy plans will face ‘ferocious’ opposition

US biotech Moderna says its vaccine can be repurposed ‘in weeks’ to deal with coronavirus mutations

Open science has been at the heart of the fight-back against the virus. As other crises loom, this underlines the need for governments to avoid protectionist moves and foster collaborative international research